Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas

Erika Gabriella Kis, Eszter Baltás, Henriette Ócsai, Attila Vass, István Balázs Németh, Erika Varga, J. Oláh, L. Kemény, Edit Tóth-Molnár

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

There is increasing evidence about the effectiveness of electrochemotherapy (ECT) in the treatment of basal cell carcinomas in the head and neck region, although its role in the management of eyelid-periocular skin tumors has to be clarified. The aim of the present study is to evaluate the results of ECT in the treatment of locally advanced primary and recurrent eyelid-periocular skin basal cell carcinomas. Twelve patients with basal cell carcinoma involving the eyelid-periocular skin region were treated with ECT. Three patients had locally advanced primary tumors, while 9 patients had recurrent tumors. All treatments were performed according to the ESOPE guidelines, using Cliniporator TM device. All patients received bleomycin based ECT. The route of administration was intratumoral in 3 patients and intravenous in 9 patients. Tumor response was evaluated using the RECIST 1.1. criteria. ECT resulted in complete response of the periocular skin tumors in all patients. Lower eyelid ectropion was developed in 3 patients which had to be corrected surgically. ECT can be used effectively in the treatment of locally advanced or recurrent basal cell carcinomas in the eyelid-periocular skin region. Excellent tumor control can be achieved with good functional and cosmetic results without systemic adverse events with short interval follow-up.

Original languageEnglish
Article number4285
JournalScientific reports
Volume9
Issue number1
DOIs
Publication statusPublished - Dec 1 2019

Fingerprint

Electrochemotherapy
Basal Cell Carcinoma
Eyelids
Skin
Neoplasms
Therapeutics
Ectropion
Bleomycin
Cosmetics
Neck
Head
Guidelines

ASJC Scopus subject areas

  • General

Cite this

Kis, E. G., Baltás, E., Ócsai, H., Vass, A., Németh, I. B., Varga, E., ... Tóth-Molnár, E. (2019). Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas. Scientific reports, 9(1), [4285]. https://doi.org/10.1038/s41598-019-41026-2

Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas. / Kis, Erika Gabriella; Baltás, Eszter; Ócsai, Henriette; Vass, Attila; Németh, István Balázs; Varga, Erika; Oláh, J.; Kemény, L.; Tóth-Molnár, Edit.

In: Scientific reports, Vol. 9, No. 1, 4285, 01.12.2019.

Research output: Contribution to journalArticle

Kis, Erika Gabriella ; Baltás, Eszter ; Ócsai, Henriette ; Vass, Attila ; Németh, István Balázs ; Varga, Erika ; Oláh, J. ; Kemény, L. ; Tóth-Molnár, Edit. / Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas. In: Scientific reports. 2019 ; Vol. 9, No. 1.
@article{4f7eb204cb6d499496bcc03e5fdab113,
title = "Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas",
abstract = "There is increasing evidence about the effectiveness of electrochemotherapy (ECT) in the treatment of basal cell carcinomas in the head and neck region, although its role in the management of eyelid-periocular skin tumors has to be clarified. The aim of the present study is to evaluate the results of ECT in the treatment of locally advanced primary and recurrent eyelid-periocular skin basal cell carcinomas. Twelve patients with basal cell carcinoma involving the eyelid-periocular skin region were treated with ECT. Three patients had locally advanced primary tumors, while 9 patients had recurrent tumors. All treatments were performed according to the ESOPE guidelines, using Cliniporator TM device. All patients received bleomycin based ECT. The route of administration was intratumoral in 3 patients and intravenous in 9 patients. Tumor response was evaluated using the RECIST 1.1. criteria. ECT resulted in complete response of the periocular skin tumors in all patients. Lower eyelid ectropion was developed in 3 patients which had to be corrected surgically. ECT can be used effectively in the treatment of locally advanced or recurrent basal cell carcinomas in the eyelid-periocular skin region. Excellent tumor control can be achieved with good functional and cosmetic results without systemic adverse events with short interval follow-up.",
author = "Kis, {Erika Gabriella} and Eszter Balt{\'a}s and Henriette {\'O}csai and Attila Vass and N{\'e}meth, {Istv{\'a}n Bal{\'a}zs} and Erika Varga and J. Ol{\'a}h and L. Kem{\'e}ny and Edit T{\'o}th-Moln{\'a}r",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-019-41026-2",
language = "English",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas

AU - Kis, Erika Gabriella

AU - Baltás, Eszter

AU - Ócsai, Henriette

AU - Vass, Attila

AU - Németh, István Balázs

AU - Varga, Erika

AU - Oláh, J.

AU - Kemény, L.

AU - Tóth-Molnár, Edit

PY - 2019/12/1

Y1 - 2019/12/1

N2 - There is increasing evidence about the effectiveness of electrochemotherapy (ECT) in the treatment of basal cell carcinomas in the head and neck region, although its role in the management of eyelid-periocular skin tumors has to be clarified. The aim of the present study is to evaluate the results of ECT in the treatment of locally advanced primary and recurrent eyelid-periocular skin basal cell carcinomas. Twelve patients with basal cell carcinoma involving the eyelid-periocular skin region were treated with ECT. Three patients had locally advanced primary tumors, while 9 patients had recurrent tumors. All treatments were performed according to the ESOPE guidelines, using Cliniporator TM device. All patients received bleomycin based ECT. The route of administration was intratumoral in 3 patients and intravenous in 9 patients. Tumor response was evaluated using the RECIST 1.1. criteria. ECT resulted in complete response of the periocular skin tumors in all patients. Lower eyelid ectropion was developed in 3 patients which had to be corrected surgically. ECT can be used effectively in the treatment of locally advanced or recurrent basal cell carcinomas in the eyelid-periocular skin region. Excellent tumor control can be achieved with good functional and cosmetic results without systemic adverse events with short interval follow-up.

AB - There is increasing evidence about the effectiveness of electrochemotherapy (ECT) in the treatment of basal cell carcinomas in the head and neck region, although its role in the management of eyelid-periocular skin tumors has to be clarified. The aim of the present study is to evaluate the results of ECT in the treatment of locally advanced primary and recurrent eyelid-periocular skin basal cell carcinomas. Twelve patients with basal cell carcinoma involving the eyelid-periocular skin region were treated with ECT. Three patients had locally advanced primary tumors, while 9 patients had recurrent tumors. All treatments were performed according to the ESOPE guidelines, using Cliniporator TM device. All patients received bleomycin based ECT. The route of administration was intratumoral in 3 patients and intravenous in 9 patients. Tumor response was evaluated using the RECIST 1.1. criteria. ECT resulted in complete response of the periocular skin tumors in all patients. Lower eyelid ectropion was developed in 3 patients which had to be corrected surgically. ECT can be used effectively in the treatment of locally advanced or recurrent basal cell carcinomas in the eyelid-periocular skin region. Excellent tumor control can be achieved with good functional and cosmetic results without systemic adverse events with short interval follow-up.

UR - http://www.scopus.com/inward/record.url?scp=85062868022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062868022&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-41026-2

DO - 10.1038/s41598-019-41026-2

M3 - Article

C2 - 30862897

AN - SCOPUS:85062868022

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 4285

ER -